Trial · NCT02705950
Intrathecal Baclofen (ITB) Bolus on Neuropathic Pain (NP). Preliminary Study.
NCT02705950, Not applicable, Completed, Institut Guttmann
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Intrathecal Baclofen (ITB) Bolus on Neuropathic Pain (NP). Preliminary Study. Trials, record NCT02705950. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02705950
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Intrathecal Baclofen (ITB) Bolus on Neuropathic Pain (NP). Preliminary Study.
- NCT number
- NCT02705950
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 12 participants, actual
- Lead sponsor
- Institut Guttmann
- Conditions
- Neuropathic Pain
- Interventions
- Intrathecal baclofen bolus, Placebo
- First posted
- 2016-03-11
- Last updated
- 2019-08-08
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Neuropathic Pain Inventory Scale (NPIS) | Change from baseline in neuropathic pain at 4hours | a self-questionnaire specifically designed to evaluate the different symptoms of neuropathic pain and includes 10 descriptors that allow discrimination and quantification of five distinct clinically relevant dimensions of neuropathic pain syndromes and that are sensitive to treatment |
| Secondary | Modified Ashworth Scale (MAS) | Change from baseline in spasticity at 1, 2 and 4hours | is to measure spasticity in patients who have lesions of the central nervous system or neurological disorders. |
| Secondary | Modified Penn Spasm Frequency Scale | Change from baseline in spasticity at 4hours | 2 component self-report measure of the frequency of reported muscle spasms which is commonly used to quantify spasticity. |
| Secondary | Visual Analogue Scale (VAS) for spasticity | Change from baseline in spasticity at 4 hours | Consists 10cm line for patient self-reporting of spasticity last 24hours |
| Secondary | warm and heat pain perception threshold | Change from baseline in warm and pain perception at 4hours | it is quantitative sensory perception test for warm perception threshold and heat pain perception threshold |
| Secondary | evoked pain perception | Change from baseline in evoked acute pain perception at 4hours | it is quantitative sensory perception test for acute induced pain perception measurement |
| Secondary | contact heat evoked potentials. | Change from baseline in evoked potential with heat pain at 4hours | It is an evoked potential induced with heat painful stimulus |
| Secondary | Brief Pain Inventory (BPI) | Change from baseline in pain at 4hours | The BPI allows patients to rate the severity of their pain and the degree to which their pain interferes with common dimensions of feeling and function. |
| Secondary | Numerical Rating Scale (NRS) for neuropathic pain | Change from baseline in pain at 4hours | Varies between 0-10 point (no pain- more severe pain) for patient self-reporting of pain for actual pain |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02705950
GET https://conductscience.org/api/trials/v1/NCT02705950/registered